For research use only. Not for therapeutic Use.
INX-SM-6（Cat No.:I043523）is an investigational small molecule compound being studied for its potential therapeutic applications in oncology. It targets specific proteins or signaling pathways involved in cancer cell proliferation, survival, and metastasis. By inhibiting these pathways, INX-SM-6 aims to reduce tumor growth and spread, potentially offering an effective treatment option for cancers that are resistant to standard therapies. Ongoing research and clinical trials are focused on evaluating its safety, efficacy, and ability to enhance the effectiveness of existing cancer treatments, particularly in solid tumors and hematologic cancers.
| CAS Number | 2734878-16-9 |
| Synonyms | (1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-[2-[(3-aminophenyl)methyl]-1,3-thiazol-5-yl]-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| Molecular Formula | C32H36N2O6S |
| Purity | ≥95% |
| IUPAC Name | (1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-[2-[(3-aminophenyl)methyl]-1,3-thiazol-5-yl]-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| InChI | InChI=1S/C32H36N2O6S/c1-30-9-8-20(36)12-18(30)6-7-21-22-13-26-32(25(38)16-35,31(22,2)14-23(37)28(21)30)40-29(39-26)24-15-34-27(41-24)11-17-4-3-5-19(33)10-17/h3-5,8-10,12,15,21-23,26,28-29,35,37H,6-7,11,13-14,16,33H2,1-2H3/t21-,22-,23-,26+,28+,29+,30-,31-,32+/m0/s1 |
| InChIKey | NJJMSRHGOQXBCC-CIIJGLHGSA-N |
| SMILES | C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(O[C@@H](O4)C5=CN=C(S5)CC6=CC(=CC=C6)N)C(=O)CO)CCC7=CC(=O)C=C[C@]37C)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
